Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Return on Invested Capital (2016 - 2025)

Haemonetics has reported Return on Invested Capital over the past 16 years, most recently at 0.09% for Q4 2025.

  • Quarterly results put Return on Invested Capital at 0.09% for Q4 2025, down 4.0% from a year ago — trailing twelve months through Dec 2025 was 0.09% (down 4.0% YoY), and the annual figure for FY2025 was 0.11%, down 2.0%.
  • Return on Invested Capital for Q4 2025 was 0.09% at Haemonetics, up from 0.09% in the prior quarter.
  • Over the last five years, Return on Invested Capital for HAE hit a ceiling of 0.15% in Q3 2023 and a floor of 0.04% in Q1 2022.
  • Median Return on Invested Capital over the past 5 years was 0.1% (2024), compared with a mean of 0.1%.
  • Biggest five-year swings in Return on Invested Capital: dropped -13bps in 2021 and later rose 9bps in 2023.
  • Haemonetics' Return on Invested Capital stood at 0.05% in 2021, then soared by 78bps to 0.1% in 2022, then grew by 8bps to 0.1% in 2023, then soared by 33bps to 0.14% in 2024, then tumbled by -33bps to 0.09% in 2025.
  • The last three reported values for Return on Invested Capital were 0.09% (Q4 2025), 0.09% (Q3 2025), and 0.09% (Q2 2025) per Business Quant data.